Hsinchu, Taiwan

Jiun-Shyang Leou

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Taipei, TW (2022)
  • Hsinchu, TW (2022 - 2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jiun-Shyang Leou: Innovator in Anti-Angiogenesis Therapeutics

Introduction

Jiun-Shyang Leou is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of anti-angiogenesis therapies. With a total of 4 patents to his name, Leou's work focuses on innovative solutions for treating diseases associated with angiogenesis.

Latest Patents

One of Leou's latest patents is titled "Anti-angiogenesis fusion protein and uses thereof." This invention presents a bi-functional fusion protein, represented as (AT)a-Fc-(VT)b, which targets both vascular endothelial growth factor (VEGF) and angiopoietins (ANGs). The components AT and VT are binding motifs for ANG and VEGF, respectively. The fragment crystallizable region (Fc) is derived from the N-terminal of Immunoglobulin G (IgG). Each of the integers a and b ranges from 1 to 10. The bi-functional fusion proteins consist of two or more domains of human proteins and are composed entirely of human sequences, making them expectedly non-immunogenic. This innovation holds potential therapeutic applications for diseases related to angiogenesis.

Career Highlights

Throughout his career, Jiun-Shyang Leou has worked with notable companies in the biotechnology sector, including Trican Biotechnology Co., Ltd. and Allgenesis Biotherapeutics Inc. His expertise in biopharmaceuticals has positioned him as a key figure in the development of innovative therapeutic solutions.

Collaborations

Leou has collaborated with several professionals in his field, including Huang-Tsu Chen and Chung-Yuan Hsu. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jiun-Shyang Leou's contributions to the field of anti-angiogenesis therapeutics highlight his innovative spirit and dedication to improving human health. His patents and collaborations reflect a commitment to advancing biopharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…